Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Compliance declines between clinic visits.

J A Cramer1, R D Scheyer, R H Mattson

  • 1Neurology Service, Veterans Affairs (VA) Medical Center, West Haven, Conn. 06516.

Archives of Internal Medicine
|July 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Oral histories document community mobilisation to participate in decision-making regarding a hazardous waste thermal treatment facility.

Local environment·2024
Same author

Limitations of T2*-Gradient Recalled-Echo and Susceptibility-Weighted Imaging in Characterizing Chronic Subdural Hemorrhage in Infant Survivors of Abusive Head Trauma.

AJNR. American journal of neuroradiology·2016
Same author

Carotid body size on CTA: correlation with comorbidities.

Clinical radiology·2013
Same author

Indirect comparison of clobazam and other therapies for Lennox-Gastaut syndrome.

Acta neurologica Scandinavica·2013
Same author

Non-interventional surveillance study of adverse events in patients with epilepsy.

Acta neurologica Scandinavica·2010
Same author

Pregnancy registries in epilepsy: a consensus statement on health outcomes.

Neurology·2008
Same journal

Elevated CK-MB With Normal Total Creatine Kinase Levels in Patients Undergoing Maintenance Hemodialysis-Reply.

Archives of internal medicine·2017
Same journal

Occult Carbon Monoxide Poisoning-Reply.

Archives of internal medicine·2017
Same journal

Acquired Immune Deficiency Syndrome-Reply.

Archives of internal medicine·2017
Same journal

Heparin Side Effects-Reply.

Archives of internal medicine·2017
Same journal

Humanizing primary care medicine begins with stress.

Archives of internal medicine·2017
Same journal

Legend omitted and number misrepresented.

Archives of internal medicine·2013
See all related articles

Patient medication adherence significantly drops over time, with compliance decreasing from 88% to 67% within a month. This highlights that infrequent drug level tests may not reflect true long-term patient drug concentrations.

Area of Science:

  • Pharmacology
  • Patient Adherence Studies
  • Clinical Monitoring

Background:

  • Medication adherence is crucial for effective treatment outcomes.
  • Assessing long-term adherence through periodic clinic visits can be challenging.
  • Current methods for evaluating drug levels may not capture adherence fluctuations.

Purpose of the Study:

  • To quantify the decline in medication adherence over time.
  • To evaluate the reliability of spot drug level tests in representing steady-state concentrations.
  • To investigate the impact of the interval between clinic visits on adherence.

Main Methods:

  • Utilized microelectronic monitors to objectively track pill-taking behavior in 20 patients.
  • Recorded medication compliance rates at baseline, post-clinic visit, and one month later.

Related Experiment Videos

  • Correlated adherence data with implications for interpreting drug serum concentrations.

    • Main Results:

    • Initial medication adherence averaged 88% before clinic visits.
    • Adherence remained high at 86% immediately following clinic visits.
    • A substantial decline in adherence to 67% was observed one month after the visit.

    Conclusions:

    • Medication adherence is not static and decreases significantly over time between clinical assessments.
    • Spot drug level measurements may not accurately represent a patient's average or steady-state drug serum concentrations.
    • Long-term adherence monitoring strategies are needed to ensure consistent therapeutic drug levels.